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Abstract: Chitosan, a well known natural cationic polysaccharide, has been successfully 
  implemented in vitro and in vivo as a nonviral delivery system for both plasmid DNA and siRNA. 
While using chitosan/siRNA polyplexes to knock down specific targets, we have underestimated 
the effect of nucleic acids binding to chitosan when extracting RNA for subsequent quantita-
tive PCR evaluation of silencing. In vitro transfection using chitosan/siRNA-based polyplexes 
reveals a very poor recovery of total RNA especially when using low cell numbers in 96 well 
plates. Here, we describe a method that dramatically enhances RNA extraction from chitosan/
siRNA-treated cells by using an enzymatic treatment with a type III chitosanase. We show that 
chitosanase treatment prior to RNA extraction greatly enhances the yield and the integrity of 
extracted RNA. This method will therefore eliminate the bias associated with lower RNA yield 
and integrity when quantifying gene silencing of chitosan-based systems using quantitative 
real time PCR.
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Chitosan is a natural polymer of β (1–4)-glucosamine and N-acetyl-D-glucosamine 
derived by partial deacetylation of chitin from crustacean shells.1 Chitosan has a pKa 
of approximately 6.5, therefore, at lower pH values, the majority of the glucosamine 
residues on chitosan is cationic due to the protonation of amine groups, which enables 
the interaction with anionic components such as nucleic acids and cell surface mac-
romolecules. Industrially, the process of partial deacetylation of chitin is controlled 
to yield specific chitosan types (or entities) characterized by their molecular weight 
(MW) as well as their degree of deacetylation (DDA). These two parameters have a 
major influence on chitosan biological and physicochemical properties.2,3 For example, 
increasing chitosan’s DDA results in reduced biodegradability and biological activity 
given that acetyl groups promote its degradation by enzymes.
Researchers have recently demonstrated the ability of chitosan to efficiently deliver 
a wide variety of biologics including proteins,4–6 plasmid DNA,7–11 and siRNA,12–14 
both in vitro and in vivo. The effectiveness of delivery is generally assessed by 
evaluating the transfection efficiency for plasmid DNA or gene silencing for siRNA. 
Quantitative assessment of gene silencing can be performed by quantitative real time 
PCR analysis of targeted genes. The sensitivity and accuracy of the latter method is 
influenced by many variables including: 1) the quality of tissues/cells, 2) the RNA 
extraction method, 3) RNA integrity, and 4) the reverse transcription and polymerase International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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chain reaction used in RT-PCR.15–18 Despite the   development 
of relative quantification techniques like the Pfaffl method19 
and the ∆∆CT method,20 RNA integrity remains an important 
issue for generating proper data. While using siRNA-chitosan 
polyplexes to knock down specific targets, we have underes-
timated the effect of nucleic acids binding to chitosan when 
extracting RNA for subsequent quantitative PCR evaluation 
of silencing. In fact, polysaccharide matrices (ie, agarose 
and alginate) used for tissue engineering have been shown 
to interfere with techniques required for protein analysis 
and with all the procedures currently used for nucleic acid 
purification.9,21,22 Moreover, our results described herein show 
that chitosan interferes with RNA extraction from low cell 
numbers. Therefore, we specifically examined this issue by 
delivering chitosan-siRNA nanoparticules against dipeptidyl 
peptidase IV (DPP-IV) mRNA in three different cell lines 
and found that siRNA-chitosan-treated cells reveal a very 
poor recovery of total RNA. The DPP-IV gene encodes a 
serine protease that cleaves the His:Ala:Glu sequence at the 
N-terminal region of the incretin hormone glucagon-like 
peptide 1 (GLP-1). GLP-1 regulates glucose homeostasis 
postprandialy thus decreasing its bioavailability and conse-
quently causing a decrease in glucose level. The inhibition of 
DPP-IV increases GLP-1 bioavailability, hence it represents 
a potential therapeutic for type II diabetes.
Here, we propose a method for overcoming low RNA 
yield from chitosan/siRNA-transfected cells by enzymati-
cally treating the cell lysate with Streptomyces griseus type 
III chitosanase in order to release mRNA that was bound to 
chitosan. In addition, we show that our technique is suitable 
for the removal of membrane bound chitosan for subsequent 
analysis by FACS of transfected cells.
Material and methods
Preparation of chitosan/sirNA polyplexes
siRNA sequences targeting the DPP-IV gene sequence were 
synthesized by Dharmacon (Thermo scientific, Dharmacon 
RNAi Technologies, USA) and are available in the On Tar-
get Plus® catalogue. The siRNA sequence has a dual strand 
modification pattern to reduce off target effects caused by 
both strands.
A 10 kDa MW chitosan with a degree of deacetylation 
(DDA) of 92% was prepared and characterized as described 
previously11 and dissolved overnight on a rotary mixer 
at 0.5% (w/v) in hydrochloric acid using a glucosamine: 
HCl ratio of 1:1. Chitosan solutions were then diluted with 
deionized water to reach the desired amine (deacetylated 
groups) to phosphate (of the nucleic acid) ratio (N/P ratio). 
Chitosan/siRNA polyplexes were formed at three different 
N/P ratios of 5, 10, and 20. Prior to mixing with siRNA, the 
diluted chitosan solutions were sterile filtered with a 0.2 µm 
syringe filter. Chitosan/siRNA nanoparticles were then pre-
pared by adding 100 µL of the sterile diluted chitosan solution 
to 100 µL of siRNA (100 nM) and mixed by rapid pipetting. 
The polyplexes were allowed to form during 30 minutes 
incubation at room temperature before transfection.
Polyplexes were measured independently using dynamic 
light scattering (DLS) and environmental scanning electronic 
microscopy (ESEM) and it was found that they had a mean 
diameter of approximately 50 nm.
cell culture
HT-29, HepG2, and Caco-2 cell lines from American Type 
Cell Culture (ATCC, Manassas, VA) were cultured in McCoys 
media (HT-29) and Dulbecco minimum essential media 
(HepG2 and CaCo-2) with 1.85 g/L of sodium bicarbonate 
and supplemented with 10% FBS (Cedarlane Laboratories, 
Burlington, ON) at 37°C and 5% CO2. These cell types 
were chosen since they express the DPP-IV enzyme and 
represent models for diabetes research. For transfection, 
HT-29, HepG2, and CaCo-2 cells were plated in 96-well 
culture plates (Corning, NY, USA) at 25,000 cells/well using 
100 µL/well of complete medium. The cells were transfected 
the following day at ∼50% confluency.
Transfection with chitosan/sirNA 
nanoparticle complexes
Complete transfection media (Dulbecco’s modified Eagle’s 
medium high glucose, 4-morpholineethanesulfonic acid 
(MES), pH 6.5) was equilibrated overnight in a 5% CO2, 
37°C incubator. Prior to transfection, pH adjustment to 
6.5 was performed with 1 N sterile HCl (Sigma-Aldrich, 
St.Louis, MO). For transfection, medium over cells was 
aspirated and replenished with 100 µL transfection medium 
(DMEM HG, MES, pH 6.5) containing chitosan/siRNA 
complexes at a concentration of 10 pmol or 50 pmoll siRNA/
well corresponding to concentrations of 100 nM or 500nM 
siRNA. Cells were incubated with chitosan/siRNA complexes 
for 24 hours until analysis. All experiments were done in 
triplicates, with a minimum of three separate experiments 
to demonstrate reproducibility.
Transfection with Dharmafect1TM
Dharmafect1TM/siRNA complexes were prepared with a 
1:2 ratio (w/v) of siRNA: Dharmafect1TM according to the 
manufacturer specifications and were used as a positive International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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control. Cells were incubated for four hours in presence of 
Dharmafect 1/siRNA complexes in serum-free medium then 
replenished with complete media (DMEM HG, 10% FBS, 
pH 7.4) and incubated for an additional 20 hours before 
analysis.
chitosanase treatment of transfected 
cells and polyplexes degradation
Cells incubated with chitosan/siRNA polyplexes for 24 hours 
were treated with chitosanase (Sigma-Aldrich, cat # C9830) 
prior to RNA extraction in order to release anionic mRNA 
from potential binding sites on chitosan. A final concentration 
of 6.12 mU of chitosanase per µg of chitosan in DMEM at 
pH 6.5 (100 µL) or in RA1 lysis buffer (100 µL) + 2 µL of 
TCEP (Macherey-NagelTM) were used. The RA1 lysis buffer 
containing chitosanase was used to assess the enzyme activity 
in presence of guanidium thiocyanate. Chitosanase resus-
pended in DMEM or in the lysis buffer was directly applied 
onto cell monolayer. Cells were then incubated at 37°C for 
60 minutes prior to RNA extraction and quantification for 
gene expression as described below.
A second set of experiments using chitosan/DPP-IVODN 
nanoparticules – with or without chitosanase treatment – were 
analyzed electrophoretically for the presence of chitosan and 
for OligoDeoxyNucleotides (ODN) release. Polyplexes were 
migrated for 120 minutes at 100V on a 13% polyacrylamide 
gel (BioRad Laboratories) in 1X MES buffer (20 mM MES, 
8 mM sodium acetate, pH 6.5) and stained using coomassie 
Brillant Blue R250 (BioRad Laboratories) for chitosan 
visualization or ethidium bromide (0.5 µg/mL) for ODN 
visualization. Gel documentation and analysis were carried 
out using the bio-vision 3000 system and the Vision-Capt 
software (Vilbert Lourmat, Marne-la-Vallée, France).
FAcs analysis
The cellular uptake of 5’6FAM labeled DPP-IVODN was ana-
lyzed using a BD Canto flow cytometer (Becton Dickinson, 
San Jose, CA) 24 hours post transfection. To determine the 
level of DNA cellular uptake, cells were transfected with 
polyplexes formed with 5’6FAM labeled DPP-IVODN as 
described above. Following 24 hours of incubation with poly-
plexes, cells were incubated with chitosanase for 60 minutes 
to dissociate and remove cell surface-associated complexes. 
For flow cytometry analysis, cells were washed twice in 
PBS, trypsinized, and resuspended in ice-cold PBS. For each 
sample, 20,000 events were counted and a dot plot of the for-
ward light scatter against the side scatter was used to   establish 
a collection gate to exclude cell debris, dead cells, and 
  aggregates of cells. The 5’6FAM-positive cells were excited 
using a 488-nm laser line and detected using a 530/30-nm 
band pass filter. To distinguish between autofluorescence and 
fluorescently labeled cells, we ran nontransfected cells as 
negative controls. The cellular uptake of the polyplexes was 
calculated as the percentage of 5’6FAM-DPP-IVODN labeled 
cells, and the relative amount of the internalized 5’6FAM-
DPP-IVODN was estimated from the median fluorescence 
intensity of the 5’6FAM-positive population.
confocal imaging
Polyplexes internalization was studied by confocal imag-
ing. Chitosans were labeled with fluorescent rhodamine B 
isothiocyanate (RITC) (Sigma-Aldrich, St-Louis, MO) and 
DPP-IVODN (21 nucleic acid) were labeled with 6-FAM on 
their 5’extremities (Integrated DNA Technologies, Inc). 
Cells were seeded 24 hours prior to transfection in 35 mm 
glass bottom culture dishes (MatTek, Ashland, MA) using 
500 µl of complete medium at 40,000 cells/dish. Chitosan/
ODN polyplexes were incubated with cells at a concentra-
tion of 2.5 µg ODN/wells in media containing 10% serum 
at pH 6.5 for 24 hours. Colocalisation was assessed quali-
tatively by the occurrence of yellow pixels resulting from 
the spatial overlap of red (Chitosan pseudocolor) and green 
pixels (ODN pseudocolor) from 2 separate channels. Prior 
to imaging, cell membranes were stained for 5 minutes at 
37°C with 5 µg/ml of Cell Mask™ Deep red (Invitrogen, 
Carlsbad, CA) in complete media followed by two washes 
with cold PBS solution and resuspension in complete media. 
Imaging of live cells was done using a Zeiss LSM 510 
META confocal Axioplan 200 microscope (Carl Zeiss AG, 
Feldbach, Switzerland).
rNA extraction and assessment  
methods (yield, purity, and integrity)
RNA extraction was performed using the RNA XS® 
extraction kit from Macherey-Nagel (Biolynx, Montréal, 
QC) according to the manufacturer protocol. For comparison 
purposes, RNA was also extracted with RNAqueous® from 
Ambion (Applied Biosystems, Streetsville, ON) according 
to the manufacturer protocol. Total RNA was quantified 
and RNA integrity measured using the Agilent BioAnalyzer 
2100 (Agilent Technologies, Mississauga, ON) following 
the manufacturer’s protocol. RNA integrity was evaluated 
by the ratio of 28S/18S ribosomal RNA (rRNA)23 and the 
RNA integrity number (RIN). Agilent 2100 BioAnalyzer 
uses automated microfluidics, capillary electrophoresis, and 
fluorescence to evaluate RNA integrity. The RIN is a related International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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measure of RNA quality that is based on a larger portion 
of the electrophoretic trace. The BioAnalyzer 2100 auto-
matically computes this parameter, and an ideal nondegraded 
RNA sample has a RIN of 10.
TaqMan® gene expression Assays: 
endogenous controls
Gene expression level for endogenous controls was deter-
mined using prevalidated Taqman Gene Expression Assays 
(Applied Biosystems, Streetsville, ON). PCR reactions 
for 384 well plate formats were performed using 2 µL of 
cDNA samples (25–50 ng), 5 µL of the Fast Universal qPCR 
MasterMix (Applied Biosystems, Streetsville, ON), 0.5 µL 
of the TaqMan Gene Expression Assay (20X), and 2.5 µL 
of water to create a total volume of 10 µL. The following 
genes were used as endogenous control: TBP (TATA binding 
protein) and HPRT (hypoxanthine guanine phosphoribosyl 
transferase).
Universal Probe Library (UPL) assays
Gene expression levels were determined using assays 
designed with the Universal Probe Library from Roche 
(http:\\www.universalprobelibrary.com). This technology 
utilizes short hydrolysis probes of 8 or 9 bases. The high 
melting temperature characteristic of longer probes is 
retained by using locked nucleic acid (LNA) nucleotide 
chemistry in these shorter probes. Since probes are only 
8 or 9 bases long, each probe can hybridize to over 7,000 
transcripts; thus, a set of only 100 probes can enable the 
quantification of virtually any transcript in a transcriptome. 
RNA samples were reverse transcribed into cDNA using the 
first strand cDNA transcriptor kit following the manufacturer 
protocol (Roche, Laval, QC). PCR reactions for 384 well 
plate formats were performed using 2 µL of cDNA samples 
(25 ng), 5 µl of the Fast Universal qPCR MasterMix (Applied 
Biosystems, Streetsville, ON), 2 µM of each primer, and 
1 µM of a UPL probe # 71 (Roche, Laval, QC) to create a 
total volume of 10 µL.
Detection and analysis
The ABI PRISM® 7900HT Sequence Detection System 
(Applied Biosystems) was used to detect cDNA amplification 
level and was programmed with an initial step of 3 minutes 
at 95°C, followed by 45 cycles of: 5 seconds at 95°C and 
30 seconds at 60°C. All reactions were run in triplicate and 
the average values of Ct (cycle threshold) were used for 
quantification. TBP and HPRT (hypoxanthine guanine phos-
phoribosyl transferase) were used as endogenous controls.
The relative quantification of target genes was determined 
using the ∆∆CT method. Briefly, the Ct values of target 
genes were referenced to an endogenous control gene 
(∆CT = Ct target − Ct endoC) and compared with a calibrator: 
∆∆CT = ∆Ct Sample − ∆Ct Calibrator. Relative expression (RQ) 
was calculated using the Sequence Detection System (SDS) 
2.2.2 software (Applied Biosystems) using the formula 
RQ = 2−∆∆CT.
statistical analysis
The measurement data were collected and expressed as 
means values ± standard deviation (SD) and were analyzed 
with Statistica 9.0 software (STATSOFT; Statistica, Tulsa, 
OK). The statistical significance was determined by one-way 
ANOVA followed by Newman–Keuls post hoc test. Differ-
ences were considered significant at P , 0.05 and highly 
significant at P , 0.01.
Results
cellular uptake
Transfection efficiency of Chitosan 92–10–5/DPP-IVODN, 
Chitosan 92–10–10/DPP-IVODN, and Chitosan 92–10–20/ 
DPP-IVODN complexes in HepG2 cells was evaluated using 
flow cytometry. We found that the sedimentation of poly-
plexes on the cell surface adds a bias to cytometry data when 
calculating the percentage of positive cells or determining 
fluorescence intensity levels to assess the amount of internal-
ized oligonucleotides.
Our results show that almost 90% ± 2 of HepG2 cells 
internalized the polyplexes and no significant difference 
between the three N/P ratios was observed (Figure 1a). Fol-
lowing chitosanase treatment, approximately a 10% reduction 
in the positive cell population was observed indicating that 
trypsinization and thorough washing alone did not fully dis-
sociate surface bound polyplexes (Figure 1a). Furthermore, 
confocal imaging shows membrane associated polyplexes 
following thorough washing which supports our FACS data. 
Although the percentage of 6FAM- DPP-IVODN positive 
cells was similar for the three N/P ratios, the amount of the 
internalized DPP-IVODN, as determined from the fluorescence 
intensity levels, varied (Figure 1b). Moreover, cells incubated 
with formulations that had higher N/P ratios showed lower 
amounts of internalized DNA. The excessive cellular uptake 
of polyplexes was further confirmed by confocal imaging, 
as shown in Figure 2. Large internalized assemblies of 
complexes were observed two hours post   incubation and an 
optimal dissociation was observed 24 hours post   transfection 
(Figure 2). The transfection efficiency of each group was International Journal of Nanomedicine 2010:5
Figure 1 FAcs analysis of chitosan/DPP-IVODN polyplexes uptake in hepg2 cell line. Uptake of 5’-6FAM labeled DPP-IVODN in chitosanase treated and untreated cells 
24 hours post transfection. (A) Transfection efficiency was calculated as the percentage of 5’FAM-DPP-IVODN labelled cells. (B) The relative amount of internalized DPP-IVODN 
was determined using flow cytometry and is expressed as the median of fluorescence intensity (FI) of the 6FAM-DPP-IVODN positive cells. Data points represent the mean 
values ± sD, n = 3.*P < 0.05; **P < 0.01.
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Figure 2 confocal imaging of polyplexes uptake. confocal microscopy images of 
hepg2 live cells 24 hours post transfection with chitosan/DPP-IVODN polyplexes 
(N/P = 5). chitosan 92–10 (DDA, MW) was labeled with rhodamine (red), the 
DPP-IVODN with 6FAM at the 5’extremity (green), and the cell membranes were 
stained prior to imaging with cell mask (blue). Membrane staining was performed to 
differentiate between internalized and membrane bound polyplexes.
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evaluated in three independent experiments using flow 
cytometry.
effect of low molecular weight  
chitosan on rNA recovery
The effect of low molecular weight chitosan (DDA = 92, 
MW = 10 kDa) at different N/P ratios on RNA extraction 
was assessed using the Bioanalyzer 2100 system (Figure 3). 
These results show very poor recovery of total RNA from 
low number cells transfected with chitosan/siRNA polyplexes 
compared to both lipofectamine-treated and nontransfected 
cells (Figure 3). We found that the majority of the samples 
had a recovery level below the detection threshold (10 ng/µl, 
RNA Integrity Number (RIN) .7). Additionally, our results 
indicated that lower N/P ratios or lower amounts of added 
polyplexes (corresponding to 50 pmol to 10 pmol siRNA 
per well) did not improve total RNA yield. The extraction 
efficiency with or without chitosanase treatment was evalu-
ated in three independent experiments with triplicates in 
each experiment.
effect of lysis buffer on  
chitosanase activity
We assessed both the effect of guanidium thiocyanate, 
a chaotropic agent, contained in commercial RA1 lysis buf-
fer, and high DDA (92% and 98% respectively) on S.griseus 
chitosanase activity. First, chitosan polyplexes were digested 
with S.griseus chitosanase and were compared to nondigested 
samples (Figure 4). Our results show that chitosan digestion 
was not affected at high DDA (98%). Moreover, DPP-IVODN 
liberated from chitosanase-treated polyplexes showed a 
quasi-total recovery indicating that smaller monomers did not 
bind nucleic acid. Second, chitosanase activity was assessed 
in lysis buffer. Our results show that S.griseus chitosanase 
activity is not altered or reduced in lysis buffer (Figure 5). 
These results suggest that the chitosanase digestion can be 
performed directly in the lysis buffer decreasing the process-
ing time of the sample (Figure 5).
gene silencing
The ability of chitosan 92–10–5 formulation to deliver 
DPP-IV siRNA in three different cell lines was assessed using 
qPCR. Our results revealed an 80% and 78%   silencing of the 
DPP-IV gene in HepG2 and Caco-2 cell lines respectively 
when compared to nontransfected cells. These results are International Journal of Nanomedicine 2010:5
Figure 3 effect of Streptomyces griseus chitosanase on yield and integrity of total rNA extraction. Total rNA extraction was performed on hepg2 cells transfected with 
10 pmol and 50 pmol of nanoparticles sirNA/chitosan at three different N/P ratios indicated by the formulation code 92-10-5, 92-10-10, or 92-10-20 (DDA, MW, N/P). 
Chitosanase was resuspended in DMEM pH 6.5 and directly applied to cells at a final concentration of 6.12 mU/µg of chitosan. Total rNA was extracted from chitosan 
transfected cell treated with or without chitosanase. The different extractions were compared to control Dharmafect™ 1 transfected cells and nontransfected (NT) cells. 
(nt) = nucleotide, L = standard ladder, the green band is a lower marker, which allows sample alignment and permits comparison for rIN calculation. rIN = rNA integrity 
number, is an algorithm-based numbering system that calculates-rNA integrity with 10 being the most intact and 1 being fully degraded.
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similar to the liposome-based positive control, Dharmafect 
1™ (Table1). Moreover, total RNA recovery from low cell 
number without chitosanase treatment was very low with RIN 
values below the set threshold accounting for the inability 
to assess gene inhibition using qPCR (Table 1). HT-29 cell 
line was difficult to transfect using this specific chitosan/
siRNA formulation due to the absence of cellular uptake as 
shown by our FACS and confocal microscopy results (data 
not shown). Although the HT-29 cell line was difficult to 
transfect, recovery of total RNA was poor, most probably 
due to extracellular excess of chitosan and to membrane 
bound polyplexes. Cellular viability in HepG2, Caco-2, and 
HT-29 cell lines was maintained after addition of the differ-
Figure  4  Polyacrylamide  gel  electrophoresis  of  chitosan/DPP-IVODN  polyplexes 
bearing different DDAs and N/P ratios, treated with or without Streptomyces griseus 
chitosanase. a) chitosan migration. b) ODN migration. Lanes 1 to 4 correspond 
to chitosan/DPP-IVODN directly incubated with chitosanase for 60 minutes at 37°c. 
chitosan digestion allows the ODN release. Lanes 5 to 8 correspond to chitosan/
DPP-IVODN incubated at the similar conditions without chitosanase. Faster chitosan 
migration was observed when comparing lanes 5 and 6 due to different MW of 
theses  formulations.  Increased  band  intensity  (lanes  6–8)  results  from  greater 
amounts of chitosan at higher N/P ratios.
With chitosanase
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Figure 5 Total rNA extraction from hepg2 transfected cells with 10 pmol sirNA.
Following transfection, cells were treated with chitosanase for: 30 min and 60 min in 
cell medium and for 60 min in lysis buffer.
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ent chitosan formulations used for transfection, dismissing 
the likelihood of toxicity effects. Gene silencing was evalu-
ated in two independent experiments in triplicates for each 
experiment.
Discussion
Current methods and commercial kits for RNA isolation are 
based on the use of acid guanidium thiocyanate buffers for 
cell lysis and protein denaturation. Depending on the methods 
used, either a phase separation followed by RNA precipitation 
is performed (TRIzol®) or silica-based matrices (RNeasy®; 
RNA XS®) are used to electrostatically bind and recover RNA 
through washing and elution steps. These methods present 
major drawbacks when large polysaccharide fragments are 
present after sample digestion. These polysaccharide frag-
ments can entrap nucleic acids physically, thus reducing RNA 
after centrifugation.24 Chitosan is a polymeric cation that has 
been shown to prevent the efficient purification of nucleic 
acids from cell entrapped matrices using available procedures 
and commercial kits.10,21 The low efficiency of purification 
is mainly due to the amine groups, which are protonated in 
acidic environments25 such as the guanidinium thiocyanate 
buffer used in both Trizol®-and silica-based kits26 hence 
promoting nucleic acid entrapment and/or binding. Another 
explanation for the poor recovery of total RNA when using 
silica-based column is that polysaccharide contaminants 
have been shown to decrease significantly the efficiency 
of spin columns.26 To resolve these issues associated with 
chitosan protonation, successful attempts have been made 
to adjust the pH of guanidinium thiocyanate extraction buf-
fers.27 However, the RNA purity ratio could not be measured 
adequately due to possible polysaccharide contamination. In 
our study, we showed that chitosan/siRNA transfection of 
low cell numbers resulted in a poor recovery of total RNA 
for subsequent transcriptomic analysis. The poor recovery 
might be due to the high binding affinity of chitosan to 
nucleic acids as recently quantified. Notably, the majority 
of the chitosan in these preparations is soluble and not com-
plexed to the polynucleotide according to our recent data 
using Asymetric Field Flow Fractionation.28 The main effect 
of chitosanase treatment may then be to eliminate the free 
fraction that could clearly bind to polyanionic mRNA and 
inhibit its extraction from chitosan-treated cells. This binding 
effect would be further accentuated in the cell lysis buffer 
containing guanidium thiocyanate which has an acidic pH 
of ∼5 and increases ionization of chitosan therefore augments 
its binding affinity to polynucleotides.
According to the hydrolysis specificity of the β-glycosidic 
linkages in partially N-acetylated chitosan molecules, chi-
tosanase can be classified into three classes. Streptomyces 
griseus chitosanase is a type III enzyme that catalyzes 
both the endohydrolysis of β-(1–4)-linkage between 
N-  acetylglucosamine and D-glucosamine (GlcNAc-GlcN) 
and between D-glucosamine (GlcN-GlcN) residues in 
chitosane.29 Sato et al found that the relative activity of the 
enzyme was 80% when degrading chitosan with 90% DDA 
compared to a 100% activity in the presence of chitosan 
with 70% DDA.29,30 However, despite a lower activity when 
degrading high DDAs chitosan (.90%), Streptomyces gri-
seus chitosanase is a powerful tool for nucleic acid recovery 
from chitosan nanoparticules bearing different DDAs, as 
shown in this study. Our results show a dramatic enhance-
ment in RNA yield and integrity when treating cells with 
S. griseus chitosanase for 60 minutes prior to extraction. In 
addition, RNA yields from transfected cells are similar to 
those of nontransfected cells, suggesting a total recovery 
of RNA from chitosan transfected cells. Furthermore, our 
results show that a 30 minute treatment can be sufficient to 
improve total RNA yield, thus reducing sample processing 
time.
Although guanidium thiocyanate is a potent chaotropic 
agent that alters dimensional structures of proteins including 
endonucleases,31 its concentration in RA1 lysis buffer does 
not seem to alter the function of this specific chitosanase. This 
Table 1 effect of chitosanase treatment on rNA extraction, relative Integrity Number (rIN), and real-time Pcr (qPcr) analysis in 
three different DPP-IV expressing cell lines. Inhibition percentages of DPP-IV gene expression in sirNA/polyplexes transfected cells 
were determined in comparison with nontransfected cells
Cell line Chitosan/siRNA Chitosan/siRNA+ chitosanase
RNA extraction qPCR RNA extraction qPCR
RIN [total RNA] ng/μl Inhibition % RIN [total RNA] ng/μl Inhibition %
hepg2 3.0 2.6 N/A 9.0 78 82
hT-29* 2.3 1.7 N/A 9.3 83 20
caco-2 4.7 3.9 N/A 8.7 76 78
*HT-29 cells were difficult to transfect.
N/A: not applicable, rIN below the set threshold required for qPcr.International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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observation is supported by the fact that some   chitosanases 
are resistant to the high concentration of denaturants such 
as urea or guanidium thiocyanate.32–34 The chitosanase 
treatment of DPP-IVODN/chitosan polyplexes permitted the 
recovery of ∼90% of the complexes ODN showing that the 
digestion of the low MW chitosan (92–10–5) into smaller 
monomers did not interact with ODN release nor with silica- 
based matrices for RNA purification.
This new method has permitted us to obtain enough RNA 
with high integrity numbers to perform subsequent real-time 
RT-PCR and analysis. Our results revealed an 80% silencing 
of the DPP-IV gene with chitosan/siRNA when compared 
to nontransfected cells. Furthermore, silencing using this 
specific formulation achieved comparable efficiencies to 
the positive control Dharmafect™1 liposome, suggesting 
the potential use of these chitosan formulations to deliver 
siRNA both in vitro and in vivo. The HT-29 cell line was 
found to be more difficult to transfect with the specific 
chitosan/siRNA formulation, in particular at the cell uptake 
level as determined by FACS and confocal microscopy (data 
not shown). This observation is supported by the fact that 
chitosan has shown cell type dependency when transfecting 
DNA plasmid.35
The silencing effect was also observed at the protein 
level where we observed a decrease in DPP-IV levels of 
approximately 55%, 48 hours post transfection (data not 
shown) demonstrating the ability of the specific chitosan 
formulation to efficiently deliver siRNA against DPP-IV 
mRNA. The FACS analysis of DPP-IVODN positive cells 
showed approximately 80% transfection efficiency follow-
ing chitosanase treatment. The latter permitted a reduction 
of ∼10% in transfection efficiency when compared to the 
chitosanase untreated cells. The 10% signal bias is pos-
sibly due to the membrane-bound chitosan as supported by 
confocal imaging. Therefore, this reduction may account 
for biased data, hence increasing accuracy of transfection 
efficiency quantification.
Conclusion
In this study, we have demonstrated the following: i) mRNA 
is difficult to extract from chitosan/siRNA-transfected cells 
for subsequent quantification of gene expression; ii) a rela-
tively simple and inexpensive technique based on enzymatic 
digestion of chitosan permits the extraction and recovery of 
total RNA for subsequent quantification of messenger levels 
by qPCR; and iii) the method described is suitable for the 
removal of membrane bound chitosan for FACS analysis of 
transfection efficiency when using labeled siRNA or ODNs, 
as a result reducing false positive data. Thus, this new method 
permits the quantification of gene silencing in chitosan deliv-
ery systems and eliminates any bias associated with chitosan 
binding to polynucleotides.
Acknowledgments
This work was supported by the Canadian Institutes of 
Health Research (CIHR) and the National Science and 
Engineering Research Council (NSERC). The authors thank 
the members of Professor Buschmann Research Group for 
their assistance.
Disclosure
The authors report no conflicts of interest in this research.
References
  1.  Illum L. Chitosan and its use as a pharmaceutical excipient. Pharm Res. 
1998;15:1326–1331.
  2.  Huang M, Khor E, Lim LY. Uptake and cytotoxicity of chitosan mol-
ecules and nanoparticles: effects of molecular weight and degree of 
deacetylation. Pharm Res. 2004;21:344–353.
  3.  Zhang H, Neau SH. In vitro degradation of chitosan by a commercial 
enzyme preparation: effect of molecular weight and degree of deacetyla-
tion. Biomaterials. 2001;22:1653–1658.
  4.  Prego C, Torres D, Alonso MJ. Chitosan nanocapsules as carriers for 
oral peptide delivery: effect of chitosan molecular weight and type 
of salt on the in vitro behaviour and in vivo effectiveness. J Nanosci 
Nanotechnol. 2006;6:2921–2928.
  5.  Prego C, Fabre M, Torres D, Alonso MJ. Efficacy and mechanism of 
action of chitosan nanocapsules for oral peptide delivery. Pharm Res. 
2006;23:549–556.
  6.  Prego C, Torres D, Fernandez-Megia E, Novoa-Carballal R, Quinoa E, 
Alonso MJ. Chitosan-PEG nanocapsules as new carriers for oral pep-
tide delivery. Effect of chitosan pegylation degree. J Control Release. 
2006;111:299–308.
  7.  Jean M, Smaoui F, Lavertu M, et al. Chitosan-plasmid nanoparticle for-
mulations for IM and SC delivery of recombinant FGF-2 and PDGF-BB 
or generation of antibodies. Gene Ther. 2009;16:1097–1110.
  8.  Centelles MN, Isasi JR, Qian C, Campanero MA, Irache JM. Influence 
of the chitosan nature on the transfection efficacy of DNA-loaded nano-
particles after hydrodynamic administration in mice. J Microencapsul. 
Feb 15 2010; [Epub ahead of print].
  9.  Zheng F, Shi XW, Yang GF, et al. Chitosan nanoparticle as gene therapy 
vector via gastrointestinal mucosa administration: results of an in vitro 
and in vivo study. Life Sci. 2007;80:388–396.
  10.  Zheng Y, Yang W, Wang C, et al. Nanoparticles based on the complex 
of chitosan and polyaspartic acid sodium salt: preparation, characteriza-
tion and the use for 5-fluorouracil delivery. Eur J Pharm Biopharm. 
2007;67:621–631.
  11.  Lavertu M, Methot S, Tran-Khanh N, Buschmann MD. High efficiency 
gene transfer using chitosan/DNA nanoparticles with specific combina-
tions of molecular weight and degree of deacetylation. Biomaterials. 
2006;27:4815–4824.
  12.  Howard KA, Rahbek UL, Liu X, et al. RNA interference in vitro and 
in vivo using a novel chitosan/siRNA nanoparticle system. Mol Ther. 
2006;14:476–484.
  13.  Futami K, Kumagai E, Makino H, et al. Anticancer activity of 
RecQL1 helicase siRNA in mouse xenograft models. Cancer Sci. 
2008;99:1227–1236.International Journal of Nanomedicine
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/international-journal-of-nanomedicine-journal
The International Journal of Nanomedicine is an international, peer-
reviewed journal focusing on the application of nanotechnology 
in diagnostics, therapeutics, and drug delivery systems throughout 
the biomedical field. This journal is indexed on PubMed Central, 
MedLine, CAS, SciSearch®, Current Contents®/Clinical Medicine, 
Journal Citation Reports/Science Edition, EMBase, Scopus and the 
Elsevier Bibliographic databases. The manuscript management system 
is completely online and includes a very quick and fair peer-review 
system, which is all easy to use. Visit http://www.dovepress.com/ 
testimonials.php to read real quotes from published authors.
International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
Dovepress
481
real-time rT-Pcr in gene silencing
  14.  Gao S, Dagnaes-Hansen F, Nielsen EJ, et al. The effect of chemical 
modification and nanoparticle formulation on stability and biodistribu-
tion of siRNA in mice. Mol Ther. 2009;17:1225–1233.
  15.  Bustin SA. Quantification of mRNA using real-time reverse 
  transcription PCR (RT-PCR): trends and problems. J Mol Endocrinol. 
2002;29:23–39.
  16.  Ginzinger DG. Gene quantification using real-time quantitative 
PCR: an emerging technology hits the mainstream. Exp Hematol. 
2002;30:503–512.
  17.  Fleige S, Walf V, Huch S, Prgomet C, Sehm J, Pfaffl MW. Com-
parison of relative mRNA quantification models and the impact of 
RNA integrity in quantitative real-time RT-PCR. Biotechnol Lett. 
2006;28:1601–1613.
  18.  Fleige S, Pfaffl MW. RNA integrity and the effect on the real-time 
qRT-PCR performance. Mol Aspects Med. 2006;27:126–139.
  19.  Pfaffl MW. A new mathematical model for relative quantification in 
real-time RT-PCR. Nucleic Acids Res. 2001;29:e45.
  20.  Arocho A, Chen B, Ladanyi M, Pan Q. Validation of the 2-∆∆Ct   
calculation as an alternate method of data analysis for quantitative   
PCR of BCR-ABL P210 transcripts. Diagn Mol Pathol. 2006;15: 
56–61.
  21.  Tchemtchoua VT, Atanasova G, Aqil A, et al. Development of a proce-
dure to simultaneously isolate RNA, DNA, and proteins for [corrected] 
characterizing cells invading or cultured on chitosan scaffolds. Anal 
Biochem. 2009;393:145–147.
  22.  Gambino G, Perrone I, Gribaudo I. A Rapid and effective method for 
RNA extraction from different tissues of grapevine and other woody 
plants. Phytochem Anal. 2008;19:520–525.
  23.  Skrypina NA, Timofeeva AV, Khaspekov GL, Savochkina LP, 
Beabealashvilli R. Total RNA suitable for molecular biology analysis. 
J Biotechnol. 2003;105:1–9.
  24.  MacRae E. Extraction of plant RNA. Methods Mol Biol. 2007;353: 
15–24.
  25.  George M, Abraham TE. Polyionic hydrocolloids for the intestinal 
delivery of protein drugs: alginate and chitosan – a review. J Control 
Release. 2006;114:1–14.
  26.  Qiagen, ed. RNeasy mini handbook. 4th ed; 2004.
  27.  Hoemann CD, Sun J, Chrzanowski V , Buschmann MD. A multivalent 
assay to detect glycosaminoglycan, protein, collagen, RNA, and DNA 
content in milligram samples of cartilage or hydrogel-based repair 
cartilage. Anal Biochem. 2002;300:1–10.
  28.  Ma PL, Lavertu M, Winnik FM, Buschmann MD. New insights into 
chitosan-DNA interactions using isothermal titration microcalorimetry. 
Biomacromolecules. 2009;10:1490–1499.
  29.  Tanabe T, Morinaga K, Fukamizo T, Mitsutomi M. Novel chitosanase 
from Streptomyces griseus HUT 6037 with transglycosylation activity. 
Biosci Biotechnol Biochem. 2003;67:354–364.
  30.  Jung HS, Son JW, Ji HS, Kim K. Effective Production of Chitinase 
and Chitosanase by Streptomyces griseus HUT 6037 Using Colloidal 
Chitin and Various Degrees of Deacetylation of Chitosan. Biotechnot 
Bioprocess Eng. 1999;4:26–31.
  31.  Mason PE, Neilson GW, Dempsey CE, Barnes AC, Cruickshank JM. 
The hydration structure of guanidinium and thiocyanate ions: implica-
tions for protein stability in aqueous solution. Proc Natl Acad Sci U S A. 
2003;100:4557–4561.
  32.  Cockle SA, Epand RM, Moscarello MA. Resistance of lipophilin, a 
hydrophobic myelin protein, to denaturation by urea and guanidinium 
salts. J Biol Chem. 1978;253:8019–8026.
  33.  Ekowati C, Hariyadi P, Witarto AB, Hwang JK, Suhartono MT.   
Biochemical characteristics of chitosanase from the Indonesian Bacillus 
licheniformis MB-2. Mol Biotechnol. 2006;33:93–102.
  34.  Yoon HG, Kim HY, Lim YH, et al. Thermostable chitosanase from Bacil-
lus sp. Strain CK4: cloning and expression of the gene and characteriza-
tion of the enzyme. Appl Environ Microbiol. 2000;66:3727–3734.
  35.  Mao HQ, Roy K, Troung-Le VL, et al. Chitosan-DNA nanopar-
ticles as gene carriers: synthesis, characterization and transfection 
  efficiency. J Control Release. 2001;70:399–421.